ACVRL1 and hereditary hemorrhagic telangiectasia: The relative prevalence of HHT is 125–200 cases/million (Shovlin, 2014), with ACVRL1 mutations accounting for 44% of affected individuals (55–88 cases/million; Kritharis et al., 2018).